- Home
- About
- People
- Research
- Publications
- Assessing the Transition from Acute to Chronic Cancer Pain (AtTACC Pain) Study
- Cannabis Multidisciplinary Education and Research (CAMERA)
- Consensus-based algorithms to address opioid misuse behaviors
- Consensus-based approach to managing opioids in patients with serious illness
- Mentoring the next generation
- Opioid therapy for pain in individuals with metastatic cancer: benefits, harms and stakeholder perspectives (BEST)
- Skills To Manage Pain (STOMP)
- Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP)
- Careers
- News & Events
- Contact
Paul Joudrey, MD, MPH
- CHAMPP Affiliate Faculty
He is Co-lead Investigator for NIDA CTN-131, a randomized pragmatic trial of office-based methadone versus buprenorphine. He received his undergraduate degree from Case Western Reserve University and his medical degree from New York University. Dr. Joudrey completed residency training at Montefiore Medical Center in the Primary Care Social Internal Medicine program and completed the National Clinician Scholars Program fellowship at Yale School of Medicine.
Dr. Joudrey grew up on his family’s apple orchard and farm market near Mansfield, Ohio. He and his sister, Anne Joudrey, co-founded North Central Ohio Harm Reduction to improve the health of people who use drugs in North Central Ohio.
Education & Training
- BA (Biology), Case Western Reserve University, 2005
- MEd (Secondary Science Education), City College of New York, 2009
- MD, New York University, 2014
- MPH (Global Public Health), New York University, 2014
- MHS (Health Services Research), Yale School of Medicine, 2019
- Internal Medicine Residency, Montefiore Medical Center Primary Care Social Internal Medicine Program, 2017
- Fellowship, National Clinician Scholars Program, Internal Medicine, Yale University School of Medicine, 2019